HM Venture Partners — Full Portfolio

Airiver Medical is a clinical-stage company developing a Drug Coated Balloon to treat respiratory tract conditions such as airway stenosis and chronic sinus inflammation.

BiotechHealthtechMedical Devices

Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.

BiotechDigital HealthMedical DevicesSan Diego, US

LYLitain Yeh(Co-Founder & Chief Executive Officer)inShunqi Yan(Co-Founder & Chief Operating Officer)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)

BoardZhang Mingyuan(Director)

Co-investorsMAMaxpro VenturesHIHighlight Capital

BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions.

BiotechHealthtechMainz, DE

OTOzlem Tureci(Executive Officer)USUgur Sahin(Executive Officer)inSPSierk Poetting(Executive Officer)inSMSean Marett(Executive Officer)inRRRyan Richardson(Executive Officer)inUŞUğur Şahin(Founder)in

Co-investorsMAManta Ray VenturesMIMIG Capital AGONOnsight VenturesPFPfizer Venture InvestmentsSASalviaANAndreessen Horowitz

Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology.

BiotechDeep TechHealthtech

Baohua Huang(Founder & CEO)

GenFleet is a biopharmaceutical company developing novel drug therapies focused on RAS targeting and antibody-drug conjugates (ADCs) to address unmet clinical needs in cancer and other serious diseases.

AI & Machine LearningBiotechHealthtechMedical DevicesBeijing, CN

Qiang LU(Founder)in

Board吕强兰炯

Co-investorsPAPan-Lin Capital

GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel.

BiotechHealthtechMedical DevicesPlymouth, US

LWLixiao Wang(Founder & Chief Executive Officer)inIan Schorn(Chief Operational Officer)inJames Ness(Chief Financial Officer)Harrison Malinoff(VP of Operations and Quality)Dave Hendrickson(VP of Research & Development)Drew McClure(VP of Market Development)in

HuidaGene develops CRISPR and RNA-guided gene editing technologies for therapeutic applications in neurology, ophthalmology, otology, myology, and hepatology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesShanghai, CN

Hui Yang(Co-Founder and Chief Scientific Advisor)

Immunotherapy oncology company engineering technologies to activate the immune system; acquired by Merck in February 2019 for $0.3B.

BiotechHealthtechMedical DevicesSeattle, US

DBDavid Baltimore(Director)Carlos V. Paya(Executive Officer, Director)Stephen R. Brady(Executive Officer)inJHJan Henrik ter Meulen(Executive Officer)Paul Rickey(Executive Officer)inWayne Gombotz(Executive Officer)in

Co-investorsAIAisling CapitalATAtlas VentureOUOUP (Osage University Partners)SASanderling VenturesSASanofi VenturesSPSPRINGROCK VENTURES+4 more

KBP is a biotechnology research and development organization that discovers and develops new therapies for unmet medical needs.

Biotech

Co-investorsBABay City Capital

Laborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.

FemTechHealthtechMedical Devices

Chris(President & CEO)

Co-investorsINInvestor

Melodi Health is a medical device company focused on breast reconstruction and breast procedures, developing implantable combination devices with expertise in infection control and plastic reconstructive surgery.

FemTechHardwareHealthtechMedical DevicesMinneapolis, US

SWSarah Worrell(Co-founder & Chief Executive Officer)inMHMichele Hilmer(Chief Strategy Officer)HMHunter Moyer, MD(Chief Medical Officer)KRKaitlyn Roth(VP Operations)inMatthew Hemsley(Director)Arikha Moses(Director)

Co-investorsENEngage Venture PartnersSOSoutheast Minnesota Capital Fund

Devices for fecal incontinence

HealthtechStewartville, US

David A. Jonas(Executive Officer, Director)Philip Conway(Executive Officer, Director)SLSarah L. Grinde(Executive Officer, Director)in

BoardAnthony Conway(Director)

Co-investorsSOSoutheast Minnesota Capital Fund

Minnesota Medical Technologies develops and manufactures continence care products, specifically fecal incontinence management devices for individual patients.

Digital HealthHealthtechMedical DevicesStewartville, US

Philip J Conway(Executive Vice President – Operations (Founder))SLSarah L Grinde(VP Marketing and Research & Development (Founder))Anthony J Conway(Chairman of the Board (Founder))LMLonnie M Boe(Executive Secretary/Office Manager (Founder))

Co-investorsSOSoutheast Minnesota Capital Fund

Neurotronic is developing Neuviant Multi-organ Denervation (MDN), an investigational catheter-based therapy that delivers ethanol to overactive sympathetic nerves near the kidneys and liver to lower blood sugar and blood pressure.

Newswise is a news distribution platform and press release service that connects journalists, public relations professionals, and the public with research news and expert sources across medical, science, life, and business sectors.

Marketing TechMedia & EntertainmentSaaS

RJRoger Johnson(Founder)inJessica Johnsonin

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies.

BiotechHealthtechCopenhagen, DK

MMMaziar Mike Doustdarin

Co-investorsNONovo Holdings

OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders.

BiotechHealthtechRockville, US

YLYang Liu(Co-founder)inPZPan Zheng(Co-founder)inMartin Devenport(Executive Officer)Michael Flaschen(Director)

Co-investors3E3E Bioventures Capital

First-in-class biologic drug targeting the CD24-Siglec innate immunity signaling pathway.

BiotechRockville, US

Pan Zheng(Executive Officer)Yang Liu(Executive Officer, Director)Martin Devenport(Executive Officer)

BoardMiao Hong(Director)Karen Liu(Director)inKun-Liang Guan(Director)

Co-investors3E3E Bioventures Capital

Developer of VT-X7 for the treatment of periprosthetic joint infection.

BiotechDallas, US

DTDavid Thompson(Executive Officer, Director)inBrian de Beaubien(Executive Officer, Director)Renee Ryan(Director)Jude Paganelli(Executive Officer, Director)

BoardMartin Sands(Director)Judson Cooper(Director)

Osteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections.

BiotechDigital HealthHealthtechMedical Devices

BDBrian de Beaubien, MD(Co-Founder & Chief Medical Officer)DTDavid Thompson(Chairman & CEO)in

UC Davis is a public tier-one research university located in Davis, California, with additional campuses and centers including UC Davis Health in Sacramento and marine and environmental research labs.

EdTechDavis, US

Co-investorsDIDigitalDx VenturesTHThe March Group

Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.

HealthtechMedical DevicesPlymouth, US

Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)

Co-investorsENEnterprise IrelandGIGilde HealthcareIRIreland Strategic Investment FundLELegend CapitalLILightstone VenturesMVMVM Life Science Partners+1 more

Verve Medical is developing the Verve RPD System, an investigational device for renal pelvic denervation—a minimally invasive catheter-based procedure that uses radiofrequency energy to disrupt overactive kidney nerves to lower blood pressure.

HealthtechMedical DevicesSanta Barbara, US

Terry Buelna(Chief Executive Officer/President/CFO)in

BoardWayne Wu(Director)

Zepto develops a targeted liquid biopsy platform for infectious disease diagnostics, offering plasma-based molecular testing through its CLIA reference laboratory and an integrated sample-to-result platform for use in hospital laboratories.

BiotechHealthtechMedical Devices

YZYongyong Zhang(Founder)in